other material
confidence high
sentiment negative
materiality 0.75
Inovio prices 15.1M share offering at $1.90, net proceeds ~$26.5M
INOVIO PHARMACEUTICALS, INC.
- Inovio sold 13.158M shares at $1.90; underwriters exercised option for 1.974M additional shares.
- Net proceeds expected ~$26.5M after discounts and expenses; closing November 12, 2025.
- Piper Sandler & Co. acted as sole book-running manager for the offering.
- Offering made under effective shelf registration statement; all shares sold by Inovio.